Neptune Technologies & Bioressources Inc. - NTB.V Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neptune Technologies & Bioressources Inc. - NTB.V

NEPT 0.200

-45.9%

Mar 6 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sultan who wrote (241)	6/16/2014 11:39:25 AM
From: The Ox	Read Replies (4) of 902

Acasti Announces Resignation of Chief Financial Officer LAVAL, Quebec, June 16, 2014 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti" or the "Corporation") ( Nasdaq:ACST) ( TSX-V:APO), an emerging biopharmaceutical company focused on the research, development and commercialization of new krill oil-based forms of omega-3 phospholipid therapies for the treatment and prevention of certain cardiometabolic disorders, announces the resignation of Xavier Harland as Chief Financial Officer of Acasti with immediate effect. "I would like to thank Xavier for his contributions over the years and wish him all the best in his future endeavours," said André Godin, Interim President and Chief Executive Officer of Acasti. Effective immediately, the functions of Chief Financial Officer for Acasti will be assumed by Mr. Godin, who is currently also Chief Financial Officer of Neptune Technologies and Bioressources.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next